Asg.V

ASG.V has a market capitalization of $18.15 million and an enterprise value to revenue ratio of 1.13, indicating a relatively low valuation compared to its revenue. The company's liquidity position is characterized as medium risk, with a debt-to-equity ratio of 0.93, suggesting a moderate level of leverage. The company holds $896,710 in cash and equivalents, but its long-term debt stands at $3.54 million, resulting in a net cash position that is negative after subtracting total debt.

Profitability metrics for ASG.V show a challenging financial landscape. The company reported a negative earnings per share (EPS) of -0.39 USD, indicating a loss per share. This loss is consistent with the company's reported revenue of $2.86 million, which is significantly lower than the $18.37 million in total revenue, suggesting a possible discrepancy or a reporting period mismatch. The company's return on invested capital (ROIC) and other profitability metrics are not provided, but the negative EPS suggests a need for improvement in operational efficiency and cost management.

ASG.V's revenue is not segmented by geographic regions or product lines in the provided data, making it difficult to assess the company's exposure to specific markets or product categories. However, the company's operations are primarily within the healthcare services and equipment industry, which is subject to regulatory and market dynamics that can affect revenue stability.

The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. The reported capital expenditure of -$543,610 indicates a reduction in capital spending, which could be a strategic move to conserve cash or a sign of operational challenges. The company's ability to grow revenue and improve profitability will depend on its capacity to manage costs and expand its market presence.

Risk factors for ASG.V include a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.93 suggests a moderate level of financial leverage, which could increase financial risk if interest rates rise or if the company's revenue does not grow as expected. The risk assessment also notes that net cash is negative after subtracting total debt, which could limit the company's ability to invest in growth opportunities or withstand financial downturns.

Recent events and filings for ASG.V are not detailed in the provided data, but the company's financial performance and risk profile suggest a need for careful monitoring of its financial health and strategic direction. The company's ability to navigate the healthcare services and equipment industry, which is subject to regulatory changes and competitive pressures, will be critical to its long-term success.